Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Andrew Ustianowski, MD, PhD
North Manchester General Hospital, United Kingdom
Poster(s):
(1353) Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study
Friday, October 13, 2023
12:15 PM – 1:30 PM
US ET
(1354) Safety of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of COVID-19: 15-Month Final Analysis of the PROVENT Phase 3 Study
Friday, October 13, 2023
12:15 PM – 1:30 PM
US ET
(2346) Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
